Author Archives: Grace Frank

#IARC2017 (Exclusive Interview) – MOXIe Trial Could Lead to First FA Treatment, Colin Meyer of Reata Says

Dr. Colin Meyer, the chief medical officer and vice president of Reata Pharmaceuticals, spoke Friday in a taped interview with reporter Patricia Inacio about omaveloxolone, an oral therapy in line to possibly become the first FDA-approved treatment for Friedreich’s ataxia. A Phase 2 clinical trial, called MOXIe (NCT02255435), is moving into a second and…